Serum 14-3-3η level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment level is predictive of DAS28 remission with tocilizumab

por Hirata, Shintaro, Marotta, Anthony, Gui, Yuan, Hanami, Kentaro, Tanaka, Yoshiya
Publicado 2015

A prospective cohort study of 14-3-3η in ACPA and/or RF-positive patients with arthralgia

por van Beers-Tas, Marian H., Marotta, Anthony, Boers, Maarten, Maksymowych, Walter P., van Schaardenburg, Dirkjan
Publicado 2016

14-3-3η Promotes Invadosome Formation via the FOXO3–Snail Axis in Rheumatoid Arthritis Fibroblast-like Synoviocytes

por Kadiri, Maleck, Charbonneau, Martine, Lalanne, Catherine, Harper, Kelly, Balg, Frédéric, Marotta, Anthony, Dubois, Claire M.
Publicado 2021

Serum levels of 14-3-3η protein supplement C-reactive protein and rheumatoid arthritis-associated antibodies to predict clinical and radiographic outcomes in a prospective cohort o...

por Carrier, Nathalie, Marotta, Anthony, de Brum-Fernandes, Artur J., Liang, Patrick, Masetto, Ariel, Ménard, Henri A., Maksymowych, Walter P., Boire, Gilles
Publicado 2016

14-3-3η is a novel mediator associated with the pathogenesis of rheumatoid arthritis and joint damage

por Maksymowych, Walter P, van der Heijde, Désirée, Allaart, Cornelia F, Landewé, Robert, Boire, Gilles, Tak, Paul P, Gui, Yuan, Ghahary, Aziz, Kilani, Ruhangiz, Marotta, Anthony
Publicado 2014